CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T), covering 2020-01-27 to 2020-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of CD19 Specific Chimeric Antigen Receptor Positive T Cells (CAR-T) in ALL and NHL [Phase 1, Phase 2]